Related by context. Frequent words. (Click for all words.) 60 cardio renal 58 CALGB 58 Translational Science Award 58 Immune Tolerance Network 58 Prostate Lung Colorectal 57 Clinical Trials Unit 57 Robert Califf 57 oral deforolimus 56 AACR publishes five 56 Stephen Freedland 56 ONTARGET 56 controlled dose escalation 55 Bowel Project NSABP 55 Network HVTN 55 BARI 2D 55 Slone Epidemiology Center 55 Autism Consortium 55 Initiates Phase II 55 multicenter prospective 54 Regado Biosciences 54 #-# Full Text 54 OSUCCC James 54 Lankenau Institute 54 Brentuximab vedotin 54 atherothrombosis 54 Phase Ib IIa 54 Completes Patient Enrollment 54 Biological Therapy 53 Arteriosclerosis Thrombosis 53 Molecular Cancer 53 NCCTG 53 rheumatoid arthritis psoriatic arthritis 53 ® bortezomib 53 recurrent glioblastoma multiforme 53 Salim Yusuf 53 forodesine 53 hepatologists 53 prospective observational 53 IGSP 53 National Surgical Adjuvant 53 PSMA ADC 52 Alzheimer Disease Cooperative 52 Meets Primary Endpoint 52 Phase Ib II 52 biostatisticians 52 Dana-Farber/Harvard Cancer Center 52 HMG CoA reductase inhibitors 52 Research CIHR 52 Chronic Heart Failure 52 Thomas E. Starzl 52 motesanib 52 Allovectin 7 ® 52 NATRECOR R 52 Metabolic Disorders 52 Winship Cancer Institute 52 phase IIb clinical 52 CrossRef Web 52 PEG SN# 52 ACNP 52 CTRC AACR San Antonio 52 CDAD Clostridium difficile 52 Dr. Rahul Singhvi 52 Max Delbrück Center 52 ThermoDox R 52 CMV vaccine 52 phase IIa clinical 52 Radiation Therapy Oncology 52 pemphigus vulgaris 51 Cardiometabolic 51 AstraZeneca Bristol Myers 51 ISPOR 51 gastrointestinal mucositis 51 Fibrillex TM 51 RE LY ® 51 patients undergoing CABG 51 biospecimen 51 ACRIN 51 Daclizumab 51 oncology cardiology 51 NewYork-Presbyterian/Columbia 51 Dana-Farber/Brigham 51 oncolytic virus therapies 51 HORIZONS AMI trial 51 RE LY 51 Agios Pharmaceuticals 51 programs visit http:/www.nih.gov 51 AIDS Clinical Trials 51 EnVivo Pharmaceuticals 51 PHT Corporation 51 Cerimon 51 Neuropharmacology 51 Phase III Clinical Trial 51 Lung Transplantation 51 Dr. Von Hoff 51 Atherosclerosis Risk 51 AIM HIGH 51 Hematologic 51 double blinded randomized 51 Inflammatory Diseases 51 GVAX R 51 R sorafenib tablets